Screening for hypovitaminosis D: cost-effective or not?

Area of Science:

• Endocrinology
• Preventive Medicine
• Nutritional Science

Background:

• The debate surrounding vitamin D screening and supplementation is highly emotive and significant.
• The U.S. Preventive Services Task Force (USPSTF) is considering updated recommendations on vitamin D screening.
• Existing scientific literature presents valid arguments both for and against vitamin D status screening.

Purpose of the Study:

• To explore the differing viewpoints on the necessity of screening for vitamin D status.
• To propose a definitive method for resolving the ongoing debate regarding vitamin D screening.

Main Methods:

• Discussion of existing scientific literature supporting both pro and con arguments for vitamin D screening.
• Proposal for a randomized controlled trial (RCT) to compare clinical outcomes in screened versus unscreened individuals.
• Identification of challenges to implementing such an RCT, including defining vitamin D sufficiency thresholds and relevant clinical endpoints.

Main Results:

• Scientifically sound arguments exist on both sides of the vitamin D screening debate.
• A randomized controlled trial is identified as the optimal method to definitively resolve the issue.
• Significant uncertainties regarding vitamin D sufficiency levels and clinical endpoints currently hinder trial feasibility.

Conclusions:

• The optimal approach to definitively resolve the vitamin D screening controversy is a randomized controlled trial.
• Current uncertainties regarding vitamin D sufficiency thresholds and clinical endpoints pose significant challenges to trial implementation.
• Further research is needed to establish clear guidelines for vitamin D screening and supplementation.